Should I open or buy a Medi-Weightloss franchise in 2027?

Everyone says Medi-Weightloss is a weight-loss clinic that'll get crushed by GLP-1 drugs like Ozempic, Wegovy, and Zepbound. I'm Kory White — 25 years in the CRO seat — and I'm here to bust that myth wide open.

Claim #1: "GLP-1s are a threat to Medi-Weightloss." Defend: Nonsense. Medi-Weightloss, founded in 2005, is a physician-supervised medical weight-loss franchise. That medical license means it can *prescribe and manage* those very GLP-1 drugs — turning the disruption into a tailwind.

The 2026 FDD shows a franchise fee of $40,000, total investment of $200,000 to $450,000, a 6%-7% royalty, and a marketing fee. Mature clinics gross $700,000 to $2,000,000, with owners clearing $120,000 to $350,000. The GLP-1 revolution isn't a threat; it's the fuel.

Patients want medical supervision for these drugs — coaching-only models are the ones in panic.

Claim #2: "It's just another weight-loss program." Defend: Wrong again. This is a medical model — lease 1,500-2,500 sq ft, medical evaluation, prescriptions (including GLP-1s), nutrition counseling, and supervision. You need a physician/medical director, but that's the moat.

The numbers: buildout $90,000-$240,000, equipment $40,000-$110,000, signage $12,000-$40,000, inventory $15,000-$45,000, initial marketing $25,000-$60,000, training $10,000-$28,000, working capital $40,000-$100,000. Total: ~$200,000-$450,000. Royalty 6%-7%, marketing fee 2%.

Revenue reality: $700K-$2M gross, owner take $120K-$350K. The medical license is the key — it's not a diet shop, it's a clinic.

Claim #3: "You need to be a doctor to own this." Defend: False. You don't need to be a physician — but you need a medical director and clinical staff. Non-clinical owners run the business while providers (physicians/NPs/PAs) deliver care.

The challenge is medical staffing, compliance, and competition for GLP-1 prescribing from telehealth and med-spas. But the GLP-1 tailwind makes demand boom — patients want medical management. The winners: operators who leverage the medical model for GLP-1 management and build recurring patient revenue.

The losers: those who can't recruit medical staff, underestimate compliance, or enter a saturated market.

Claim #4: "The market is dead for weight-loss franchises." Defend: Dead wrong. The weight-loss/obesity treatment market is exploding with GLP-1 awareness. Medi-Weightloss's physician supervision and GLP-1 management differentiate it from coaching-only models.

Recurring patients provide recurring revenue. The 90-day decision tree: Day 1-20 read the FDD and medical requirements; Day 21-45 interview 8+ owners about GLP-1 demand, staffing, and net profit; Day 46-65 validate market and line up a medical director; Day 66-100 build and staff; Day 101-130 open with patient acquisition and GLP-1 management; then leverage the medical model to provide GLP-1 prescribing and supervision.

Ongoing: build recurring patient relationships and manage compliance.

Claim #5: "There's no alternative if this fails." Defend: There are alternatives — Profile by Sanford (coaching/nutrition, must adapt to GLP-1s), Ideal Image (med-spa/aesthetics, may offer GLP-1s), Restore Hyper Wellness/IV-wellness (broader wellness), med-spa franchises, independent medical weight-loss clinics (full control, no brand/systems), and other medical/wellness franchises.

But Medi-Weightloss's medical model turns the GLP-1 disruption into an advantage — it's not competing with the drugs, it's prescribing them.

The bottom line: Open a Medi-Weightloss clinic if you want a physician-supervised medical weight-loss franchise that rides the GLP-1 wave, can fund $200K-$450K, and will manage medical staffing and compliance. Skip it if you can't handle medical staff, compliance, or a saturated market.

For medical-business operators, it's a strong, GLP-1-aligned play — the medical model is the key.

*This isn't investment advice — just a CRO's take. For deeper dives on franchise economics and market timing, check out PULSE or the CRO Syndicate.*

*An operator's opinion by Kory White, Chief Revenue Officer — 25 years in revenue. More at PULSE · CRO Syndicate*